Hypothesis

Telomere length does not merely count divisions; it sets the topological entropy of chromatin by regulating the formation of G-quadruplex structures at telomeric repeats. This entropy feeds back onto mitochondrial function through PARP-mediated NAD+ consumption, creating a measurable link between replicative history and cellular metabolic state.

Mechanistic Basis

Short telomeres increase the density of TTAGGG repeats, favoring intramolecular G-quadruplex formation. These structures impede replication and transcription, raising local chromatin supercoiling. Cells respond by activating PARP1, which binds DNA lesions and consumes NAD+ to add poly-ADP-ribose chains. Elevated PARP activity lowers the NAD+/NADH ratio, diminishing SIRT3 deacetylase activity in mitochondria, which suppresses oxidative phosphorylation and ATP production. Conversely, telomerase-mediated telomere elongation reduces G-quadruplex load, lessening PARP demand and preserving NAD+ for sirtuin-driven metabolic programs. Mitochondrial metabolites such as alpha-ketoglutarate and acetyl-CoA (see Epigenetic links to telomere-proximal chromatin) further modulate histone marks, creating a feedback loop where metabolic state influences telomere chromatin accessibility.

Testable Predictions

1. G-quadruplex quantification – Using BG4 antibody staining or G4-specific sequencing, cells with experimentally shortened telomeres (via CRISPR-mediated TRF1 knockout) will show higher telomeric G-quadruplex signal than controls with long telomeres (via TERT overexpression).
2. PARP activity correlation – Telomere-shortened cells will exhibit increased PARP1 autophosphorylation and reduced intracellular NAD+ levels, reversible by PARP inhibition (e.g., olaparib) or by supplementation with NAD+ precursors (NR, NMN).
3. Mitochondrial output – Oxygen consumption rate (OCR) and ATP production will be depressed in short-telomere cells and rescued by either PARP inhibition or NAD+ boosting, independent of telomerase activity.
4. Cancer cell phenotype – Tumor lines that maintain short telomeres yet high telomerase (e.g., many carcinomas) will display low telomeric G-quadruplex burden, low PARP activity, and high NAD+/NADH ratios compared with senescent fibroblasts of comparable telomere length.
5. Pharmacological test – Treatment with a G-quadruplex stabilizer (e.g., pyridostatin) in long-telomere cells should phenocopy telomere shortening: increased PARP activation, NAD+ depletion, and mitochondrial dysfunction, even when telomerase is active.

Potential Implications

If validated, this model reframes telomere length as a physical encoder of informational entropy that directly couples the nuclear genome to mitochondrial energetics. It offers a mechanistic bridge between the telomere as a clock view and the emerging concept of aging as a thermodynamic cost of biological computation. Therapeutically, targeting telomeric G-quadruplexes or PARP-NAD+ signaling could modulate metabolic decline in aging or alter the entropic state that cancer cells exploit to reset their replicative clock.